These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24920577)

  • 21. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of Tobacco Industry Research on Packaging Colors for Designing Health Warning Labels.
    Lempert LK; Glantz SA
    Nicotine Tob Res; 2016 Sep; 18(9):1910-4. PubMed ID: 27146637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents.
    Anderson SJ
    Tob Control; 2011 May; 20 Suppl 2(Suppl_2):ii20-8. PubMed ID: 21504928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of the tobacco industry documents for public health and policy.
    Bero L
    Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.
    LeGresley E; Lee K
    Tob Control; 2017 May; 26(3):316-322. PubMed ID: 27354678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003.
    Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K
    Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations.
    Velicer C; Glantz SA
    PLoS One; 2015; 10(12):e0142032. PubMed ID: 26717245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-cigarettes and Weight Loss-Product Design Innovation Insights From Industry Patents.
    Singh H; Kennedy RD; Lagasse LP; Czaplicki LM; Cohen JE
    Nicotine Tob Res; 2018 Jul; 20(8):1010-1014. PubMed ID: 28525609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Keep a low profile": pesticide residue, additives, and freon use in Australian tobacco manufacturing.
    Chapman S
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii45-53. PubMed ID: 14645948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How tobacco companies have used package quantity for consumer targeting.
    Persoskie A; Donaldson EA; Ryant C
    Tob Control; 2018 May; ():. PubMed ID: 29853560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Containing diffusion: the tobacco industry's multipronged trade strategy to block tobacco standardised packaging.
    Crosbie E; Eckford R; Bialous S
    Tob Control; 2019 Mar; 28(2):195-205. PubMed ID: 29680829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?
    Wen CP; Chen T; Tsai YY; Tsai SP; Chung WS; Cheng TY; Levy DT; Hsu CC; Peterson R; Liu WY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i38-44. PubMed ID: 15923447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
    Peeters S; Gilmore AB
    PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menthol cigarettes and smoking initiation: a tobacco industry perspective.
    Klausner K
    Tob Control; 2011 May; 20 Suppl 2(Suppl_2):ii12-9. PubMed ID: 21504927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of cigarette pack shape, size and opening: evidence from tobacco company documents.
    Kotnowski K; Hammond D
    Addiction; 2013 Sep; 108(9):1658-68. PubMed ID: 23600674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Waiting for the opportune moment: the tobacco industry and marijuana legalization.
    Barry RA; Hiilamo H; Glantz SA
    Milbank Q; 2014 Jun; 92(2):207-42. PubMed ID: 24890245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market.
    Holden C; Lee K
    Global Health; 2011 May; 7():15. PubMed ID: 21595921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An extremely compensatible cigarette by design: documentary evidence on industry awareness and reactions to the Barclay filter design cheating the tar testing system.
    Kozlowski LT; Dreschel NA; Stellman SD; Wilkenfeld J; Weiss EB; Goldberg ME
    Tob Control; 2005 Feb; 14(1):64-70. PubMed ID: 15735303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.
    Crosbie E; Bialous S; Glantz SA
    Tob Control; 2019 Dec; 28(e2):e110-e118. PubMed ID: 30659106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.